The performance of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key territories has introduced substantial uncertainty . Investors are now grappling with the impact of lower-cost